跳至主要内容
临床试验/JPRN-UMIN000050925
JPRN-UMIN000050925招募中Unknown

An observational study of the safety and efficacy of nivolumab as adjuvant treatment for esophageal cancer using the Comprehensive Registry of Esophageal Cancer in the National Clinical Database. - An observational study of the safety and efficacy of adjuvant nivolumab therapy for esophageal cancer.

Japanese Foundation For Cancer Research0 个研究点目标入组 1,750 人开始时间: 2023年4月25日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
1,750